InnoCore Pharmaceuticals Email Formats
Pharmaceutical Manufacturing • 
Groningen, Groningen, Netherlands • 21-50 Employees
InnoCore Pharmaceuticals Email Formats
InnoCore Pharmaceuticals uses 4 email formats. The most common is {first initial}.{last name} (e.g., j.doe@innocorepharma.com), used 50% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@innocorepharma.com | 50% |
{first name}.{last name} | john.doe@innocorepharma.com | 29.4% |
{first initial} | j@innocorepharma.com | 14.7% |
{first name} | john@innocorepharma.com | 5.9% |
Key Contacts at InnoCore Pharmaceuticals
Rudy Mareel
Non Executive Director
Rob Steendam
Chief Technology Officer
Dirk Jan Van Drooge
Director Development
Jan Hendriks
Non Executive Director
Wilma Steeman
Director Operations
Company overview
| Headquarters | L.J Zielstraweg 1, Groningen, Nederland 9713 GX, NL |
| Phone number | +31505753100 |
| Website | |
| NAICS | 3254 |
| SIC | 283 |
| Keywords | Plga, Solid Implants, Hydrogel, Long Acting Injectables, Drug Eluting Stent Coatings, In-Situ Forming Implants, Injectable Microspheres, Low Solubles, Synbiosys Polymers |
| Founded | 2003 |
| Employees | 21-50 |
| Socials |
About InnoCore Pharmaceuticals
InnoCore specializes in the formulation, process development, and manufacturing of long acting and minimally invasive injectable drug delivery products. InnoCore offers a unique and highly tunable polymer platform to control the delivery drug compounds, including small molecules (e.g. peptides and low solubles) and biologics (e.g. proteins and antibodies). Our proprietary polymer platform features a variety of benefits to your API's such as: - solving toxicity challenges - maintaining/increasing stability and structural integrity of sensitive compounds (e.g. by applying low temperature process conditions during manufacturing) - sustained release of of drug molecules from days up to at least 6 months - precise control over particle size (preventing absorption by macrophages and ensuring injectability) - ensuring smooth bioavailability - enabling the use of small needle sizes for patient compliance By merging developmental collaborations and licensing partnerships with our exclusive SynBiosys biodegradable polymer technologies, we generate innovative injectable and implantable drug delivery products. We invite you to navigate through our website and discover how we can enhance the performance of your device and/or drug and add value to your product pipeline.
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
InnoCore Pharmaceuticals has 23 employees across 5 departments.
Departments
Number of employees
Funding Data
InnoCore Pharmaceuticals has never raised funding before.
InnoCore Pharmaceuticals Tech Stack
Discover the technologies and tools that power InnoCore Pharmaceuticals's digital infrastructure, from frameworks to analytics platforms.
CDN
Web servers
CDN
Security
JavaScript libraries
Tag managers
Cookie compliance
Security
JavaScript libraries
Cookie compliance
SSL/TLS certificate authorities
JavaScript libraries
India
Sweden
Italy
United States
Australia
Frequently asked questions
4.8
40,000 users
